Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04378101 · ClinicalTrials.gov registry record
Eating Disorders Genetics Initiative
A clinical trial of Anorexia Nervosa and Binge-Eating Disorder, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 17,991
- Enrollment target
- 3
- Study locations
NCT04378101: Completed study of Anorexia Nervosa and Binge-Eating Disorder, sponsored by University of North Carolina, Chapel Hill.
NCT04378101 is a study of Anorexia Nervosa and Binge-Eating Disorder that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 17,991 participants, above the 532-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (3282% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04378101, a study of Anorexia Nervosa and Binge-Eating Disorder, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 17,991 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overarching intention of the Eating Disorder Genetics Initiative (EDGI) is to lay the foundation for all future genomic discovery in eating disorders--anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED)--by exploring both genetic and behavioral factors. To do this, information will be collected from 4000 people who have provided DNA samples for the Anorexia Nervosa Genetics Initiative (ANGI) and the same information and DNA will be collected from an additional 16,000 people. The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed.
Primary Outcome
The ED100K is a web-based diagnostic questionnaire, based on the Structured Clinical Interview for Axis 1 Disorders, that applies algorithms to participant responses. The number of participants with each diagnosis (AN, BN, BED, and control) will be reported.
Conditions Studied
Interventions
- OTHER Eating disorder diagnosis group
Study Locations (3)
North Carolina
- University of North Carolina - Chapel Hill
Queensland
- QIMR Berghofer - Brisbane
Canterbury
- University of Otago - Christchurch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,991 participants |
| Start Date | 2020-06-12 |
| Est. Completion | 2023-05-31 |
What the finished NCT04378101 record still lists
NCT04378101 is an observational study that tracks outcomes without assigning an intervention. Its 17,991 participants enrollment target places it among the larger protocols in the corpus, above the 532-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (3282% higher).
The record links to 3 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 1 intervention - of which Eating disorder diagnosis group is the first listed.
NCT04378101 reports a single indexed study location in North Carolina, Queensland, Canterbury.
Frequently Asked Questions
What is clinical trial NCT04378101 about?
NCT04378101 is a clinical study titled "Eating Disorders Genetics Initiative". The overarching intention of the Eating Disorder Genetics Initiative (EDGI) is to lay the foundation for all future genomic discovery in eating disorders--anorexia nervosa (AN), bulimia nervosa (BN), and binge-eating disorder (BED)--by exploring both genetic and behavioral factors. To do this, infor...
What is the current status of trial NCT04378101?
This trial is currently completed. The enrollment target is 17,991 participants. The study started on 2020-06-12. Estimated completion is 2023-05-31.
What conditions does trial NCT04378101 study?
This clinical trial studies the following conditions: Anorexia Nervosa, Binge-Eating Disorder, Bulimia Nervosa.
What interventions are being tested in trial NCT04378101?
The interventions under investigation include: Eating disorder diagnosis group (OTHER).
Who is sponsoring clinical trial NCT04378101?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04378101 being conducted?
This trial has 3 study locations across North Carolina, Queensland, Canterbury. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anorexia Nervosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04378101's enrollment target sits among peer trials
17,991 2nd of 43 the highest of 43 other Anorexia Nervosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
RECRUITING · NA
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
RECRUITING · NA
-
Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa
RECRUITING · NA
-
Eating Disorders Genetics Initiative 2
RECRUITING
-
Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04110522 · 18,000 participants · NA
Psoriatic Arthritis D2P Screening
- NCT05513833 · 18,000 participants · NA
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
- NCT06802224 · 18,000 participants · Phase 4
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
- NCT07108660 · 17,800 participants · NA
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI